Apollomics, Inc. (APLMW:NASDAQ) closed at $0.011 on October 23, 2026, up 2.75% on the day. The stock trades 56.9% below its 52-week high of $0.026 and 10.9% above its 52-week low of $0.010. Apollomics, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, APLMW closed higher on 25 days (10%). Its best day was June 30, 2026 (+142.17%) and its worst was March 6, 2026 (-50.00%). The stock moved 10% or more in a single session 26 times. It opened at least 5% above the previous day's high 56 times.
Apollomics Inc is an innovative clinical-stage biotechnology company. It is is focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. It has a pipeline of 9 drug candidates across multiple programs, 6 of which are in the clinical stage of development.
Find more stocks like APLMW with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.